BioXcel Therapeutics, Inc. (BTAI) › Weighted Average Diluted SharesBioXcel Therapeutics, Inc. (BTAI) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 21.68M2021-12-31: 26.37M2022-12-31: 28.02M2023-12-31: 1.82M2024-12-31: 2.54M2025-12-31: 12.21M12.21M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3112.21M+381.6%2026-03-27From 2025-01-012024-12-312.54M+39.2%2026-03-27From 2024-01-012023-12-311.82M-93.5%2025-03-28From 2023-01-012022-12-3128.02M+6.2%2024-03-22From 2022-01-012021-12-3126.37M+21.6%2023-03-16From 2021-01-012020-12-3121.68M—2022-03-11From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)